Health and life sciences

Finland’s health innovation ecosystem brings together startups, corporates, healthcare providers, and researchers. Collaboration is structured through pilots, shared platforms, and co-development models. Companies can test ideas, form partnerships, and move from pilot to commercialization with fewer detours.

Why Finland

• An active startup scene working closely with corporate and public partners
• Access to incubators, accelerators, and test environments
• Collaboration across health, ICT, and industrial sectors
• Clear routes from pilot projects to commercial adoption

What companies do in practice

• Co-develop solutions with startups and research groups
• Run pilots in healthcare settings
• Invest through corporate venture capital
• Build long-term partnerships across the ecosystem

Finland connects quantum computing with life sciences research, enabling new approaches in drug discovery, molecular modeling, and complex data analysis. Quantum systems are connected to national high-performance computing resources.

Why Finland

• Quantum systems run alongside supercomputers to solve real problems
• AI and life sciences turn quantum advances into usable tools
• Public funding backs deep tech through pilots proving quantum value
• Researchers link quantum methods to life science use cases

What companies do in practice

• Explore quantum methods for drug discovery
• Combine quantum and classical computing workflows
• Collaborate with research institutes and universities
• Build early-stage quantum life sciences applications

Health technology in Finland is developed and tested within a digital healthcare system. Companies work with hospitals, care providers, and patients to validate devices, software, and data-driven services in real use. Testing, integration, and regulatory preparation happen early, reducing barriers to EU rollout.

Why Finland

• A digitized healthcare system with high‑quality data
• Testbeds and living labs for devices and digital solutions
• Strong expertise in sensors, software, and wireless systems
• Growing focus on areas like women’s health

What companies do in practice

• Test medical devices and digital health applications
• Develop remote monitoring and diagnostics
• Integrate solutions with clinical workflows
• Prepare products for EU market entry

Finland supports pharmaceutical and biotech projects from early research to clinical trials and manufacturing. Companies benefit from skilled talent, structured collaboration with healthcare providers, and access to population-level health data.

Why Finland

• Proven track record in clinical trials and real-world evidence-based studies
• Access to longitudinal health data and biobanks
• Competitive cost structure for R&D and manufacturing
• Public–private collaboration with hospitals and research institutes

What companies do in practice

• Run clinical trials and real-world evidence studies
• Develop biologics and advanced therapies
• Set up R&D or production operations
• Collaborate with healthcare providers and researchers